Spots Global Cancer Trial Database for Clinical Utility for Ion Endoluminal System
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Utility for Ion Endoluminal System
Official Title: PRECIsE: A Prospective Evaluation of the Clinical Utility for the Ion Endoluminal System
Study ID: NCT03893539
Interventions
Study Description
Brief Summary: The goal of this prospective, multi-center, single-arm, clinical study is to evaluate the clinical utility and performance of the FDA-cleared Ion™ Endoluminal System ("Ion") for bronchoscopically approaching and facilitating the tissue sampling of pulmonary nodules.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States
Henry Ford Health System, Detroit, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States
MD Anderson Cancer Center, Houston, Texas, United States
Contact Details
Name: Erik Folch, MD
Affiliation: Massachusetts General Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
